US Patent Issued to Juno Therapeutics on July 7 for "Antibodies and chimeric antigen receptors specific for CD19" (Washington Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,000, issued on July 7, was assigned to Juno Therapeutics Inc. (Seattle).

"Antibodies and chimeric antigen receptors specific for CD19" was invented by Yan Chen (Seattle), Steven M. Shamah (Seattle), Csaba Pazmany (Seattle) and Jui Dutta-Simmons (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are CD19 binding molecules, including anti-CD19 antibodies, including antibody fragments such as single-chain fragments, and chimeric receptors including the antibodies, such as chimeric antigen receptors (CARs). Among the antibodies are human antibodies, including those that compete for binding to CD19 with reference antibodies, such as murine a...